# DNA X, Inc. (SONM)

> Technology · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SONM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ 5.09M | $ -5.56M | $ 2.40M | $ -1.23M |
| 2025 | $ 0 | $ -21.15M | $ -24.09M | $ 5.07M | $ -6.73M |
| 2024 | $ 61.28M | $ -35.37M | $ -9.14M | $ 0 | $ -5.70M |
| 2023 | $ 101.24M | $ -97.3K | $ -4.42M | $ 55.0K | $ 22.37M |
| 2022 | $ 78.01M | $ -15.74M | $ -13.82M | $ 213.0K | $ 20.05M |
| 2021 | $ 64.86M | $ -45.91M | $ -45.79M | $ 214.0K | $ 18.63M |
| 2020 | $ 81.52M | $ -38.13M | $ -13.96M | $ 362.0K | $ 28.41M |
| 2019 | $ 150.05M | $ -33.35M | $ -45.02M | $ 10.18M | $ 25.53M |
| 2018 | $ 179.17M | $ 1.69M | $ 1.74M | $ 13.51M | $ 5.13M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.95 |
| Liabilities / Eq | -4.67 |
| Current Ratio | 0.57 |

## Other views

- [Metrics](https://sponda.capital/en/SONM.md)
- [Charts](https://sponda.capital/en/SONM/charts.md)
- [Compare](https://sponda.capital/en/SONM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.